Table 3.
Univariable correlates of 90-day mortality in BJH cohort
| Variable | Overall (N=303) | Alive at 90 days (N=249) | Dead at 90 days (N=45) | P-value |
|---|---|---|---|---|
| Caucasian, No. (%) | 227 (75%) | 189 (76%) | 32 (71%) | 0.57 |
| Male, No. (%) | 239 (79%) | 198 (80%) | 33 (73%) | 0.43 |
| Age (years) | 56.19 ± 11.91 | 55.94 ± 11.99 | 58.98 ± 9.94 | 0.11 |
| BMI | 28.93 ± 6.19 | 28.79 ± 6.12 | 29.81 ± 6.27 | 0.31 |
| Strategy, No. (%) | 0.020 | |||
| • Bridge to Transplant | 204 (67%) | 176 (71%) | 23 (51%) | |
| • Destination Therapy | 95 (31%) | 71 (29%) | 21 (47%) | |
| History of Atrial Fibrillation, No. (%) | 130 (43%) | 107 (43%) | 21 (47%) | 0.74 |
| Smoking within 3 months, No. (%) | 29 (10%) | 22 (9%) | 6 (14%) | 0.41 |
| History of CAD, No. (%) | 155 (51%) | 121 (49%) | 30 (67%) | 0.034 |
| STEMI in past 30 days, No. (%) | 12 (4%) | 11 (4%) | 0 (0%) | 0.23 |
| History of DM, No. (%) | 126 (42%) | 99 (40%) | 23 (51%) | 0.19 |
| COPD, No. (%) | 40 (13%) | 34 (14%) | 6 (13%) | 1.00 |
| History of Ethanol Abuse, No. (%) | 2 (13%) | 2 (18%) | 0 (0%) | 1.00 |
| History of hypertension, No. (%) | 145 (48%) | 119 (48%) | 22 (49%) | 1.00 |
| Ischemic cardiomyopathy, No. (%) | 136 (45%) | 109 (44%) | 22 (49%) | 0.63 |
| CABG at time of implant No. (%) | 14 (6%) | 9 (5%) | 4 (11%) | 0.12 |
| Redo sternotomy, No. (%) | 67 (28%) | 56 (28%) | 10 (29%) | 1.00 |
| Vasopressors prior to VAD, No. (%) | 35 (14%) | 22 (11%) | 11 (29%) | 0.008 |
| Inpatient inotropes prior to VAD, No.(%) | 214 (86%) | 171 (84%) | 34 (89%) | 0.62 |
| IABP prior to VAD, No. (%) | 64 (25%) | 50 (25%) | 12 (31%) | 0.43 |
Comparisons of patients alive and dead at 90 days were conducted with Student’s two sample t-test and Fisher’s exact test for continuous and categorical data, respectively. The p value for the difference between the 2 groups is indicated. VAD = Ventricular assist device; BMI = Body Mass Index; CAD = coronary artery disease; IABP = intra-aortic balloon pump, CABG = coronary artery bypass grafting